FDA free to pursue semaglutide compounders after latest court ruling
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.
FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinoma
Granite Bio secures $100m in funding for new antibodies
EC grants orphan drug designation to Dyne Therapeutics’ DMD therapy
Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds
MSD’s Gardasil sales slide further due to China constraints
Analysis
View More
Themes
View MoreAstraZeneca enters $200m AI cancer pact with Tempus and Pathos
AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View MoreDigital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
3 reasons why biotechs preparing for launch need a compliant content foundation
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
EU Health Data Space strikes a chord in EU harmonisation plans